TVTX

Travere Therapeutics, Inc. Common Stock
Data: 2026-04-02
$30.26
Price
-3.29%
Change
$40.9899
52W High
$12.91
52W Low

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Quick Stats
Apr 02, 2026

65.0

AI Score

BUY

0.51

Volume Ratio

May 07, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

TVTX Stock Summary

Last updated Apr 02, 2026

TVTX is currently trading at $30.26, positioned above its 200-day moving average of $26.51, indicating a long-term uptrend. The stock has a 52-week range of $12.91 to $40.9899.

Technical Analysis: The 50-day moving average stands at $29.22, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 57.097, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.238, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates TVTX at 65.0/100 with a BUY recommendation.

TVTX (Travere Therapeutics, Inc. Common Stock) Indicators

Last updated Apr 02, 2026

Indicator Value
RSI(14) 57.097
CMF (20) 0.238
ROC (10) 9.614
ADX (14) 25.247
Indicator Value
MACD (12,26,9) 0.04
AROONOSC (14) 57.143
WILLAMS %R (14) -24.51
MFI (14) 64.582
TVTX Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

TVTX Price vs Max Options Open Interest
TVTX Max Change In Options Open Interest

TVTX Options - Sort by Max open Interest (near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

TVTX Daily Out of Money Options - Sort by Max open Interest (near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

TVTX Daily In the Money Options - Sort by Max open Interest (near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

TVTX Most Active Options by Volume(near term)

2nd April 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Travere Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.

TVTX Moving Averages Analysis

Travere Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 02, 2026

Travere Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 02, 2026

TVTX (Travere Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Apr 02, 2026

Days MA
10 28.33
20 28.12
30 28.55
50 29.22
100 32.01
200 26.51

TVTX Fundamental Analysis

P/E (Forward) 45.4545
P/E (Trailing) --
Market Cap ($) 2.7 billion
Earnings/Share ($) -0.57
Net Proft Margin (%) -0.0521
Dividend/Share ($) --
EPS Estimate Current Year ($) 1.5871
EPS Estimate Next Year ($) 4.2614
WallStreet Target Price ($) 42.5
Most Recent Quarter